Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles. / Alfaro Nuñez, Luis Alonso; Bertelsen, Mads Frost; Bojesen, Anders Miki; Rasmussen, Isabel; Zepeda Mendoza, Marie Lisandra; Olsen, Morten Tange; Gilbert, M. Thomas P.

In: B M C Evolutionary Biology, Vol. 14, 206, 2014.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Alfaro Nuñez, LA, Bertelsen, MF, Bojesen, AM, Rasmussen, I, Zepeda Mendoza, ML, Olsen, MT & Gilbert, MTP 2014, 'Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles', B M C Evolutionary Biology, vol. 14, 206. https://doi.org/10.1186/s12862-014-0206-z

APA

Alfaro Nuñez, L. A., Bertelsen, M. F., Bojesen, A. M., Rasmussen, I., Zepeda Mendoza, M. L., Olsen, M. T., & Gilbert, M. T. P. (2014). Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles. B M C Evolutionary Biology, 14, [206]. https://doi.org/10.1186/s12862-014-0206-z

Vancouver

Alfaro Nuñez LA, Bertelsen MF, Bojesen AM, Rasmussen I, Zepeda Mendoza ML, Olsen MT et al. Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles. B M C Evolutionary Biology. 2014;14. 206. https://doi.org/10.1186/s12862-014-0206-z

Author

Alfaro Nuñez, Luis Alonso ; Bertelsen, Mads Frost ; Bojesen, Anders Miki ; Rasmussen, Isabel ; Zepeda Mendoza, Marie Lisandra ; Olsen, Morten Tange ; Gilbert, M. Thomas P. / Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles. In: B M C Evolutionary Biology. 2014 ; Vol. 14.

Bibtex

@article{c0c245fa715c417da7a0352dfd06e6ca,
title = "Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles",
abstract = "BackgroundFibropapillomatosis (FP) is a neoplastic disease characterized by cutaneous tumours that has been documented to infect all sea turtle species. Chelonid fibropapilloma-associated herpesvirus (CFPHV) is believed to be the aetiological agent of FP, based principally on consistent PCR-based detection of herpesvirus DNA sequences from FP tumours. We used a recently described PCR-based assay that targets 3 conserved CFPHV genes, to survey 208 green turtles (Chelonia mydas). This included both FP tumour exhibiting and clinically healthy individuals. An additional 129 globally distributed clinically healthy individual sea turtles; representing four other species were also screened.ResultsCFPHV DNA sequences were obtained from 37/37 (100{\%}) FP exhibiting green turtles, and 45/300 (15{\%}) clinically healthy animals spanning all five species. Although the frequency of infected individuals per turtle population varied considerably, most global populations contained at least one CFPHV positive individual, with the exception of various turtle species from the Arabian Gulf, Northern Indian Ocean and Puerto Rico.Haplotype analysis of the different gene markers clustered the CFPHV DNA sequences for two of the markers (UL18 and UL22) in turtles from Turks and Caicos separate to all others, regardless of host species or geographic origin.ConclusionPresence of CFPHV DNA within globally distributed samples for all five species of sea turtle was confirmed. While 100{\%} of the FP exhibiting green turtles yielded CFPHV sequences, surprisingly, so did 15{\%} of the clinically healthy turtles. We hypothesize that turtle populations with zero (0{\%}) CFPHV frequency may be attributed to possible environmental differences, diet and/or genetic resistance in these individuals. Our results provide first data on the prevalence of CFPHV among seemingly healthy turtles; a factor that may not be directly correlated to the disease incidence, but may suggest of a long-term co-evolutionary latent infection interaction between CFPHV and its turtle-host across species. Finally, computational analysis of amino acid variants within the Turks and Caicos samples suggest potential functional importance in a substitution for marker UL18 that encodes the major capsid protein gene, which potentially could explain differences in pathogenicity. Nevertheless, such a theory remains to be validated by further research.",
keywords = "The Faculty of Health and Medical Sciences, Co-evolution, Sea turtles, Herpesvirus, Fibropapillomatosis, Tunours, Latency, CFPHV",
author = "{Alfaro Nu{\~n}ez}, {Luis Alonso} and Bertelsen, {Mads Frost} and Bojesen, {Anders Miki} and Isabel Rasmussen and {Zepeda Mendoza}, {Marie Lisandra} and Olsen, {Morten Tange} and Gilbert, {M. Thomas P.}",
year = "2014",
doi = "10.1186/s12862-014-0206-z",
language = "English",
volume = "14",
journal = "B M C Evolutionary Biology",
issn = "1471-2148",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - Global distribution of Chelonid fibropapilloma-associated herpesvirus among clinically healthy sea turtles

AU - Alfaro Nuñez, Luis Alonso

AU - Bertelsen, Mads Frost

AU - Bojesen, Anders Miki

AU - Rasmussen, Isabel

AU - Zepeda Mendoza, Marie Lisandra

AU - Olsen, Morten Tange

AU - Gilbert, M. Thomas P.

PY - 2014

Y1 - 2014

N2 - BackgroundFibropapillomatosis (FP) is a neoplastic disease characterized by cutaneous tumours that has been documented to infect all sea turtle species. Chelonid fibropapilloma-associated herpesvirus (CFPHV) is believed to be the aetiological agent of FP, based principally on consistent PCR-based detection of herpesvirus DNA sequences from FP tumours. We used a recently described PCR-based assay that targets 3 conserved CFPHV genes, to survey 208 green turtles (Chelonia mydas). This included both FP tumour exhibiting and clinically healthy individuals. An additional 129 globally distributed clinically healthy individual sea turtles; representing four other species were also screened.ResultsCFPHV DNA sequences were obtained from 37/37 (100%) FP exhibiting green turtles, and 45/300 (15%) clinically healthy animals spanning all five species. Although the frequency of infected individuals per turtle population varied considerably, most global populations contained at least one CFPHV positive individual, with the exception of various turtle species from the Arabian Gulf, Northern Indian Ocean and Puerto Rico.Haplotype analysis of the different gene markers clustered the CFPHV DNA sequences for two of the markers (UL18 and UL22) in turtles from Turks and Caicos separate to all others, regardless of host species or geographic origin.ConclusionPresence of CFPHV DNA within globally distributed samples for all five species of sea turtle was confirmed. While 100% of the FP exhibiting green turtles yielded CFPHV sequences, surprisingly, so did 15% of the clinically healthy turtles. We hypothesize that turtle populations with zero (0%) CFPHV frequency may be attributed to possible environmental differences, diet and/or genetic resistance in these individuals. Our results provide first data on the prevalence of CFPHV among seemingly healthy turtles; a factor that may not be directly correlated to the disease incidence, but may suggest of a long-term co-evolutionary latent infection interaction between CFPHV and its turtle-host across species. Finally, computational analysis of amino acid variants within the Turks and Caicos samples suggest potential functional importance in a substitution for marker UL18 that encodes the major capsid protein gene, which potentially could explain differences in pathogenicity. Nevertheless, such a theory remains to be validated by further research.

AB - BackgroundFibropapillomatosis (FP) is a neoplastic disease characterized by cutaneous tumours that has been documented to infect all sea turtle species. Chelonid fibropapilloma-associated herpesvirus (CFPHV) is believed to be the aetiological agent of FP, based principally on consistent PCR-based detection of herpesvirus DNA sequences from FP tumours. We used a recently described PCR-based assay that targets 3 conserved CFPHV genes, to survey 208 green turtles (Chelonia mydas). This included both FP tumour exhibiting and clinically healthy individuals. An additional 129 globally distributed clinically healthy individual sea turtles; representing four other species were also screened.ResultsCFPHV DNA sequences were obtained from 37/37 (100%) FP exhibiting green turtles, and 45/300 (15%) clinically healthy animals spanning all five species. Although the frequency of infected individuals per turtle population varied considerably, most global populations contained at least one CFPHV positive individual, with the exception of various turtle species from the Arabian Gulf, Northern Indian Ocean and Puerto Rico.Haplotype analysis of the different gene markers clustered the CFPHV DNA sequences for two of the markers (UL18 and UL22) in turtles from Turks and Caicos separate to all others, regardless of host species or geographic origin.ConclusionPresence of CFPHV DNA within globally distributed samples for all five species of sea turtle was confirmed. While 100% of the FP exhibiting green turtles yielded CFPHV sequences, surprisingly, so did 15% of the clinically healthy turtles. We hypothesize that turtle populations with zero (0%) CFPHV frequency may be attributed to possible environmental differences, diet and/or genetic resistance in these individuals. Our results provide first data on the prevalence of CFPHV among seemingly healthy turtles; a factor that may not be directly correlated to the disease incidence, but may suggest of a long-term co-evolutionary latent infection interaction between CFPHV and its turtle-host across species. Finally, computational analysis of amino acid variants within the Turks and Caicos samples suggest potential functional importance in a substitution for marker UL18 that encodes the major capsid protein gene, which potentially could explain differences in pathogenicity. Nevertheless, such a theory remains to be validated by further research.

KW - The Faculty of Health and Medical Sciences

KW - Co-evolution

KW - Sea turtles

KW - Herpesvirus

KW - Fibropapillomatosis

KW - Tunours

KW - Latency

KW - CFPHV

U2 - 10.1186/s12862-014-0206-z

DO - 10.1186/s12862-014-0206-z

M3 - Journal article

VL - 14

JO - B M C Evolutionary Biology

JF - B M C Evolutionary Biology

SN - 1471-2148

M1 - 206

ER -

ID: 127663256